Tag: Drug repositioning

According to a 2020 study, 108 branded drugs approved between 1983 and 2017 in the U.S. had multiple orphan indications, demonstrating that a drug can have multiple orphan drug designations. This practice of pursuing multiple indications for the same drug has significant implications for patients, pharmaceutical companies, and the broader healthcare system.

Developing a new drug can take over 13.5 years and cost billions [1.5.5]. So, **what is the drug tensor?** It is not a single medication, but an advanced computational concept using artificial intelligence to dramatically accelerate and refine this process [1.5.1, 1.4.1].

With an estimated 1.6 million new cases occurring annually, leishmaniasis primarily affects impoverished communities in Africa, Asia, and Latin America [1.6.3]. The search for safer, more effective treatments has led scientists to ask: **can ivermectin treat leishmaniasis?**